IMCLONE SYSTEMS INCORPORATED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
  
 
C07K PEPTIDES 1135
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6852533 Purified populations of stem cellsJan 25, 99Feb 08, 05[C12N]
6086896 Antigenic iron repressible protein from N. meningitidis related to the hemolysin family of toxinsOct 14, 94Jul 11, 00[A61K, G01N, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8623604 Methods for predicting responsiveness of a cancer cell to an anti-IGFR1 antibody by analysis of mutations in PIK3CAExpiredSep 09, 10Jan 07, 14[C12Q]
2009/0099,339 ANTIBODY AND ANTIBODY FRAGMENTS FOR INHIBITING THE GROWTH OF TUMORSAbandonedJul 09, 08Apr 16, 09[C07K]
2009/0060,909 ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITYAbandonedMar 26, 08Mar 05, 09[A61K, A61P]
2009/0048,301 HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTICANCER AGENTSAbandonedJul 09, 04Feb 19, 09[A61K, C07D, A61P]
2009/0022,714 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonistAbandonedOct 20, 06Jan 22, 09[A61K, A61P]
2008/0317,750 ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITYAbandonedMar 26, 08Dec 25, 08[A61K]
2008/0311,121 ANTIBODY ANTAGONISTS OF VE-CADHERIN WITHOUT ADVERSE EFFECTS ON VASCULAR PERMEABILITYAbandonedMar 26, 08Dec 18, 08[A61K, A61P]
2008/0171,050 TREATMENT OF HYPERPROLIFERATIVE DISEASES WITH EPIDERMAL GROWTH FACTOR RECEPTOR ANTAGONISTSAbandonedNov 30, 07Jul 17, 08[A61K, A61P]
2008/0118,480 Methods and Compositions for Directing Migration of Neural Progenitor CellsAbandonedDec 20, 04May 22, 08[A61K, C12N, A61P]
7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeabilityExpiredJan 02, 02May 13, 08[C12N]
2008/0008,704 Methods of treating colorectal cancer with anti-epidermal growth factor antibodiesAbandonedApr 02, 07Jan 10, 08[A61K, A61P]
2007/0282,373 Hemostatic Pressure PlugAbandonedNov 24, 04Dec 06, 07[A61B]
7112653 Composition and method for preserving progenitor cellsExpiredDec 15, 03Sep 26, 06[C12N]
2006/0154,334 Method of producing an antibody to epidermal growth factor receptorAbandonedSep 20, 05Jul 13, 06[C07H, C12P, C12N, C07K]
7060808 Humanized anti-EGF receptor monoclonal antibodyExpiredJun 07, 96Jun 13, 06[C07H]
6991794 Progenitor cell preservation factors and methods for and products of their useExpiredDec 30, 99Jan 31, 06[A61K]
2005/0181,997 Progenitor cell preservation factors and methods for and products of their useAbandonedMar 16, 05Aug 18, 05[A61K, C07H, C12Q, C12N, C07K]
2005/0142,659 Purified populations of stem cellsAbandonedDec 16, 04Jun 30, 05[C12N]
2005/0060,779 Lectin-derived progenitor cell preservation factors and methods of useAbandonedAug 30, 04Mar 17, 05[C07H, C12N, A01H]
6852321 Lectin-derived progenitor cell preservation factor and methods of useExpiredOct 29, 01Feb 08, 05[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.